» Articles » PMID: 2466050

Autoimmune T Lymphocytes in Myasthenia Gravis. Determination of Target Epitopes Using T Lines and Recombinant Products of the Mouse Nicotinic Acetylcholine Receptor Gene

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1989 Mar 1
PMID 2466050
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Oligoclonal and cloned T lines from peripheral blood or thymuses of patients with myasthenia gravis (MG) were selected for reactivity against nicotinic acetylcholine receptors (AChR) from Torpedo california, or against a recombinant fusion peptide, X4, representing the extracellular portion of the mouse AChR alpha-chain. All cell lines expressed the CD4 membrane phenotype, and their antigen reactivity was blocked by antibodies against monomorphic HLA DR/DP determinants. Using a panel of fusion proteins of different, overlapping mouse AChR alpha-chain sequences, a major T cell epitope was localized between amino acid positions 85 and 142. This determinant was distinct from the humoral main immunogenic region, which has been identified on the sequence 61-76. The response pattern of uncloned T lines from three patients with different HLA haplotypes suggests, however, that in any one MG patient T lymphocytes may recognize more than one autoantigenic epitope on the AChR alpha-chain, and that the T lymphocyte response profiles vary among individual patients.

Citing Articles

Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.

Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S Blood. 2004; 105(2):735-41.

PMID: 15454488 PMC: 1847365. DOI: 10.1182/blood-2003-11-3900.


Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem).

Lin M, Fu C, Aoki V, Hans-Filho G, Rivitti E, Moraes J J Clin Invest. 2000; 105(2):207-13.

PMID: 10642599 PMC: 377431. DOI: 10.1172/JCI8075.


Current and future therapies for myasthenia gravis.

Yi Q, Lefvert A Drugs Aging. 1997; 11(2):132-9.

PMID: 9259176 DOI: 10.2165/00002512-199711020-00005.


A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses.

Kirshner S, Dayan M, Zisman E, Fridkin M, Wirguin I, Sela M Proc Natl Acad Sci U S A. 1997; 94(7):3200-5.

PMID: 9096370 PMC: 20346. DOI: 10.1073/pnas.94.7.3200.


Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.

Lin M, Swartz S, Lopez A, Ding X, Fernandez-Vina M, Stastny P J Clin Invest. 1997; 99(1):31-40.

PMID: 9011573 PMC: 507764. DOI: 10.1172/JCI119130.


References
1.
Wekerle H, Ketelsen U . Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet. 1977; 1(8013):678-80. DOI: 10.1016/s0140-6736(77)92118-3. View

2.
Schmidt J, RAFTERY M . A simple assay for the study of solubilized acetylcholine receptors. Anal Biochem. 1973; 52(2):349-54. DOI: 10.1016/0003-2697(73)90036-5. View

3.
Lindstrom J, Campbell M, Nave B . Specificities of antibodies to acetylcholine receptors. Muscle Nerve. 1978; 1(2):140-5. DOI: 10.1002/mus.880010206. View

4.
Lindstrom J . Autoimmune response to acetylcholine receptors in myasthenia gravis and its animal model. Adv Immunol. 1979; 27:1-50. DOI: 10.1016/s0065-2776(08)60261-8. View

5.
Lemke H, Hammerling G, Hammerling U . Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice. Immunol Rev. 1979; 47:175-206. DOI: 10.1111/j.1600-065x.1979.tb00293.x. View